Latest Updates

Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round

DST’s Technology Development Board extends financial support to Nagpur-based Nitika for manufacturing 14 advanced excipients under…

Indoco Remedies UK begins distribution of cardiovascular treatment via Clarity Pharma across the United Kingdom

Dr Adatia to support Oliver Wyman’s healthcare and investor-focused strategy in India with cross-sector experience and digital…

Nair to take charge from July 1, 2025; joins Cipla’s senior management with focus on global manufacturing and compliance

Pharma companies exporting to the US should now rightly be on guard and start preparing for the inevitable “knock on the factory…

The tablets, used for treating IBS-D in adults, will be manufactured at the company’s SEZ II facility in Ahmedabad

While CAR-Ts are transforming blood cancer treatment, their struggle in solid tumors highlights the urgent need for innovation in…

Kunal Gupta, Partner, White-Collar Crime Practice and Sahil Bansal, Counsel - White-Collar Crime Practice, Trilegal stress that…

Masurkar has pledged to help mobilise collaborative initiatives that promote research-led development, facilitate strategic…

Interim results showed that sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour…

Mahesh Krishnamoorthy, Managing Director, Core Integra stresses that compliance in pharma is non-negotiable; highlights seven key…

The merger will bring together two business verticals—Global Animal Health and an integrated API business

The location offers easy access to major ports including Hazira, Dahej, Kandla, and Mundra, ensuring connectivity for both imports…

The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…

Rakesh Gupta, Managing Partner, LoEstro Advisors, explains that speed, quality, and transparency will be the key differentiators…

The new services - CI6/SIS/CISC2 and SI8/AIS5 – offer expanded market access for Indian exporters and importers

GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…

Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…

Novel tear-based biomarker aims at earlier intervention and improved patient outcomes in Keratoconus